NKX2-5 and coronary artery disorder: We have previously shown that a CHD-causing NKX2-5 variant and a synthetic variant completely lacking the homeodomain (HD) retain the ability to bind and regulate a subset of normal NKX2-5 WT targets, whilst also binding to many unique “off-targets” leading to their modified expression33.